Neuroone Medical Technologies (NMTC) Change in Account Payables (2016 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Change in Account Payables came in at -$33326.0 in Q2 2026, up 90.94% on a YoY basis from -$17453.6 in Q2 2025, and down 108.76% quarter-over-quarter from $380240.0 in Q1 2026.
Powered by 
Analysis
Neuroone Medical Technologies (NMTC) Change in Account Payables (2016 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has reported Change in Account Payables for 10 consecutive years, with -$33326.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Account Payables rose 90.94% year-over-year to -$33326.0; the trailing twelve-month figure through Jun 2026 stood at $433865.0 (up 263.87% YoY), and the FY2025 full-year result was $239983.0, up 258.22% from the prior year.
- Change in Account Payables eased to -$33326.0 in Q2 2026 per NMTC's latest filing, from $380240.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $602635.0 in Q3 2022 and bottomed at -$439992.0 in Q4 2025.
- Historically, Change in Account Payables has averaged $10609.7 across 5 years, with a median of -$23525.5 in 2024.
- The widest YoY moves for Change in Account Payables: up 3746.27% in 2025, down 2845.26% in 2025.
- Over 5 years, Change in Account Payables stood at -$154098.0 in 2022, then jumped by 151.61% to $79527.0 in 2023, then sank by 118.78% to -$14939.0 in 2024, then slumped by 2845.26% to -$439992.0 in 2025, then jumped by 92.43% to -$33326.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$33326.0, $380240.0, and -$439992.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -52.50 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | - |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 71.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Neuroone Medical Technologies | 14.10 Mn | 12.05 Mn | 1.18 Mn | -33,326.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -33,326.00 |
| Mar 31, 2026 | 380,240.00 |
| Dec 31, 2025 | -439,992.00 |
| Sep 30, 2025 | 526,943.00 |
| Jun 30, 2025 | -367,845.00 |
| Mar 31, 2025 | 95,824.00 |
| Dec 31, 2024 | -14,939.00 |
| Sep 30, 2024 | 22,206.00 |
| Jun 30, 2024 | -32,112.00 |
| Mar 31, 2024 | -2,628.00 |
| Dec 31, 2023 | 79,527.00 |
| Sep 30, 2023 | -184,381.00 |
| Jun 30, 2023 | -37,946.00 |
| Mar 31, 2023 | 129,236.00 |
| Dec 31, 2022 | -154,098.00 |
| Sep 30, 2022 | 602,635.00 |
| Jun 30, 2022 | -120,997.00 |
| Mar 31, 2022 | -257,372.00 |
| Dec 31, 2021 | 291,172.00 |
| Sep 30, 2021 | 115,815.00 |